Atara Biotherapeutics
ATRA
ATRA
134 hedge funds and large institutions have $776M invested in Atara Biotherapeutics in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 47 increasing their positions, 41 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
7% less funds holding
Funds holding: 144 → 134 (-10)
15% less capital invested
Capital invested by funds: $910M → $776M (-$133M)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
Holders
134
Holding in Top 10
2
Calls
$2.32M
Puts
$407K
Top Buyers
| 1 | +$10.2M | |
| 2 | +$7.51M | |
| 3 | +$5.8M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$5.23M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$4.81M |
Top Sellers
| 1 | -$5.45M | |
| 2 | -$4.24M | |
| 3 | -$2.98M | |
| 4 |
Renaissance Technologies
New York
|
-$2.68M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.15M |